Diabetes Mellitus, Type 1
1,132
86
117
802
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
220 trials with published results (19%)
Research Maturity
802 completed trials (71% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.7%
64 terminated out of 1132 trials
92.6%
+6.1% vs benchmark
17%
189 trials in Phase 3/4
27%
220 of 802 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 802 completed trials
Clinical Trials (1132)
STOP-T1D Low-Dose (ATG)
An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1D
Tandem Freedom - Feasibility Trial 2
Improving Diabetes in Emerging Adulthood
Device Use Reimagined Through Education And Mentorship
The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France
Keeping in Touch (KiT) With Youth as They Transition to Adult Type 1 Diabetes Care
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Multimorbidity Typology, Trajectory, and Feasibility of an Audio Diary Mobile Application to Support Self-management
Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells
Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature
Study to Evaluate the Safety and Feasibility of Diamyd® in Individuals at Risk for Type 1 Diabetes
Effectiveness of a Combined mHealth-CBT Psychological Intervention to Improve Psychological Well-Being in Young Patients With T1D
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults
HOME-AHCL: Home-Based Implementation of an Advanced Hybrid Closed-Loop System With Telemonitoring in Type 1 Diabetes
National Institute of Diabetes and Digestive Kidney Diseases* Share Plus: Continuous Glucose Monitoring With Data Sharing in Older Adults With Type 1 Diabetes* and Their Care Partners to Improve Time in Range and Reduce Diabetes Distress.
Type 1 Diabetes and Diabetes Distress
User Experience With DuraTouch® in Patients With Type 1 or Type 2 Diabetes